Target intelligence / Profile preview

Catabolism

01

Overview

Catabolism is a fundamental metabolic process that involves the breakdown of complex molecules into simpler units, typically releasing energy in the process. This energy, often in the form of ATP, is essential for various cellular functions, and the smaller molecules produced serve as building blocks for other synthetic processes. Examples of catabolic processes include the breakdown of carbohydrates, proteins, and fats. While catabolism is vital for life, its dysregulation is implicated in numerous diseases, including type II diabetes, metabolic syndrome, cancer, and conditions characterized by excessive tissue wasting like the Persistent Inflammation, Immunosuppression, and Catabolism Syndrome (PICS). Catabolism itself is a broad biological process, not a single molecular target like a receptor or enzyme. Therefore, drugs do not 'target' catabolism directly, but rather modulate specific enzymes or pathways within catabolic networks to influence the overall process. Modulating these pathways can have significant therapeutic implications, but also carries potential safety concerns due to the fundamental role of catabolism in maintaining cellular homeostasis and energy balance.

Other names
destructive metabolismcatabolic reactions
02

Mechanism of action

Drugs do not directly target 'Catabolism' as a single entity, but rather modulate specific enzymes or pathways involved in catabolic processes. For example, Etomoxir inhibits carnitine palmitoyltransferase 1 (CPT1), an enzyme crucial for lipid catabolism. Orlistat blocks lipid synthesis and lipolysis. Anabolic steroids like oxandrolone exert anti-catabolic effects by decreasing protein degradation and increasing protein synthesis. Hormones such as cortisol, glucagon, and adrenaline are naturally occurring catabolic agents that stimulate various breakdown processes. Anti-inflammatory agents like anakinra and tocilizumab can indirectly alleviate hypercatabolic states by reducing systemic inflammation. Propranolol, a beta-adrenergic receptor blocker, can inhibit lipolysis and improve protein synthesis.

03

Biological functions

Breakdown of complex molecules into smaller unitsEnergy generation (ATP production)Production of smaller molecules for synthesisMuscle tissue breakdownDegradation of proteins, polysaccharides, and lipids
04

Disease associations

Type II diabetesMetabolic syndromeCancerPersistent Inflammation, Immunosuppression, and Catabolism Syndrome (PICS)Aging-related muscle lossMalnutritionSepsisAIDSRenal failureHypothyroidism
05

Safety considerations

Inappropriate activation of catabolic pathways can lead to pathological outcomes, such as DNA damage.Broad modulation of catabolism can lead to significant metabolic disturbances, including weight gain or loss.Improper use of anti-inflammatory agents to reduce catabolism may have adverse effects by blocking relevant signaling pathways.Hepatotoxicity is a concern with some anabolic steroids used to counteract catabolism.Hypoglycemia is a major complication with insulin used as an anabolic agent.
06

Interacting drugs

Etomoxir

8 more in the full profile.

Beyond the preview

Go deeper on Catabolism.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Catabolism.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call